Teladoc Health, Inc. (TDOC)
NYSE · Services-Offices & Clinics Of Doctors Of Medicine · Services · CIK 1477449 · fiscal year ends in Dec
Closing price $8.73 on 29 Oct 2026; 52-week range $4.47 to $9.72.
Key figures
The last twelve months reported, with the latest price and balance sheet.
- Revenue, last twelve months
- $2.5B
- Revenue growth
- -2.4%
- Net income, last twelve months
- -$154.8M
- Earnings per share
- -$0.86
- Gross margin
- 68.6%
- Operating margin
- -6.6%
- Net margin
- -6.3%
- Free cash flow
- $262.0M
- Return on equity
- -12.0%
- Market value
- $1.6B
- Cash
- $849.9M
- Debt
- $997.6M
- Debt to equity
- 0.77
- Shares outstanding
- 182.3M
Financial statements
Revenue, profit and cash flow by fiscal year, each year linked to its annual report.
| Fiscal year | Year end | Revenue | Operating income | Net income | EPS | Free cash flow | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | 31 Dec 2025 | $2.5B | -$263.0M | -$200.3M | -$1.14 | $285.5M | 10-K filed 26 Feb 2026 |
| FY2024 | 31 Dec 2024 | $2.6B | -$1.0B | -$1.0B | -$5.87 | $282.9M | 10-K filed 27 Feb 2025 |
| FY2023 | 31 Dec 2023 | $2.6B | -$248.6M | -$220.4M | -$1.34 | $338.6M | 10-K filed 23 Feb 2024 |
| FY2022 | 31 Dec 2022 | $2.4B | -$13.7B | -$13.7B | -$84.60 | $172.8M | 10-K filed 1 Mar 2023 |
| FY2021 | 31 Dec 2021 | $2.0B | -$265.6M | -$428.8M | -$2.73 | $185.5M | 10-K filed 1 Mar 2023 |
By quarter
| Quarter | Quarter end | Revenue | Net income | EPS |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sep 2026 | $605.1M | -$26.9M | -$0.15 |
| Q2 FY2026 | 30 Jun 2026 | $606.9M | -$38.9M | -$0.21 |
| Q1 FY2026 | 31 Mar 2026 | $613.8M | -$63.8M | -$0.36 |
| Q4 FY2025 | 31 Dec 2025 | $642.3M | -$25.1M | -$0.14 |
| Q3 FY2025 | 30 Sep 2025 | $626.4M | -$49.5M | -$0.28 |
| Q2 FY2025 | 30 Jun 2025 | $631.9M | -$32.7M | -$0.19 |
| Q1 FY2025 | 31 Mar 2025 | $629.4M | -$93.0M | -$0.53 |
| Q4 FY2024 | 31 Dec 2024 | $640.5M | -$48.4M | -$0.28 |
Revenue by segment
As the company reports it in the segment note of its annual report.
By business, FY2025
| Segment | Revenue | Share |
|---|---|---|
| Integrated Care | $1.6B | 62.4% |
| BetterHelp | $950.4M | 37.6% |
By product, FY2025
| Segment | Revenue | Share |
|---|---|---|
| Access Fees | $2.1B | 82.7% |
| Other | $438.0M | 17.3% |
By region, FY2025
| Segment | Revenue | Share |
|---|---|---|
| United States | $2.1B | 81.9% |
| Non-US | $458.2M | 18.1% |
Company events
The newest 8-K filings of 146 held.
| Filed | Form | Event | Items |
|---|---|---|---|
| 28 Oct 2026 | 8-K | Results | 2.02, 9.01 |
| 25 Sep 2026 | 8-K | Leadership change | 5.02 |
| 31 Aug 2026 | 8-K | Leadership change, Investor update | 5.02, 7.01, 9.01 |
| 13 Aug 2026 | 8-K | Leadership change | 5.02 |
| 3 Aug 2026 | 8-K | Leadership change, Investor update | 5.02, 7.01, 9.01 |
| 29 Jul 2026 | 8-K | Results | 2.02, 9.01 |
| 21 May 2026 | 8-K | Shareholder vote | 5.07 |
| 29 Apr 2026 | 8-K | Results | 2.02, 9.01 |
| 30 Mar 2026 | 8-K | Leadership change, Investor update | 5.02, 7.01, 9.01 |
| 25 Feb 2026 | 8-K | Results | 2.02, 9.01 |
| 18 Feb 2026 | 8-K | Leadership change, Investor update | 5.02, 7.01, 9.01 |
| 12 Feb 2026 | 8-K | Leadership change | 5.02 |
Every filing
The newest filings with the SEC of 359 held.
| Filed | Form | Period |
|---|---|---|
| 29 Oct 2026 | 10-Q | 30 Sep 2026 |
| 28 Oct 2026 | 8-K | 28 Oct 2026 |
| 25 Sep 2026 | 8-K | 24 Sep 2026 |
| 31 Aug 2026 | 8-K | 27 Aug 2026 |
| 13 Aug 2026 | 8-K | 10 Aug 2026 |
| 3 Aug 2026 | 8-K | 3 Aug 2026 |
| 30 Jul 2026 | 10-Q | 30 Jun 2026 |
| 29 Jul 2026 | 8-K | 29 Jul 2026 |
| 26 May 2026 | SD | – |
| 21 May 2026 | 8-K | 21 May 2026 |
| 30 Apr 2026 | 10-Q | 31 Mar 2026 |
| 29 Apr 2026 | 8-K | 29 Apr 2026 |
Insider trades
Form 4 trades by officers, directors and 10% owners, last 12 months.
| Traded | Insider | Type | Shares | Price | Value | Held after | Form 4 |
|---|---|---|---|---|---|---|---|
| 2 Oct 2026 | Catapano Joseph Ronald, Chief Accounting Officer | Sale outside a trading plan | 655 | $5.65 | $3.7K | 14,293 | 5 Oct 2026 |
| 11 Sep 2026 | Divita Charles Iii, CHIEF EXECUTIVE OFFICER | Sale outside a trading plan | 17,805 | $6.10 | $108.7K | 465,535 | 14 Sep 2026 |
| 3 Sep 2026 | Rodrigues Fernando M., President of BetterHelp | Sale under a trading plan | 9,812 | $6.51 | $63.9K | 0 | 3 Sep 2026 |
| 2 Sep 2026 | Nueno Carlos, President, International | Sale outside a trading plan | 6,200 | $6.30 | $39.1K | 64,744 | 3 Sep 2026 |
| 2 Sep 2026 | Vandervoort Adam C, CHIEF LEGAL OFFICER, SECRETARY | Sale outside a trading plan | 7,573 | $6.30 | $47.7K | 117,616 | 3 Sep 2026 |
| 2 Sep 2026 | Bliss Kelly, President, U.S. Group Health | Sale outside a trading plan | 7,357 | $6.30 | $46.4K | 92,832 | 3 Sep 2026 |
| 2 Sep 2026 | Catapano Joseph Ronald, Chief Accounting Officer | Sale outside a trading plan | 274 | $6.30 | $1.7K | 12,865 | 3 Sep 2026 |
| 2 Sep 2026 | Divita Charles Iii, CHIEF EXECUTIVE OFFICER | Sale outside a trading plan | 18,327 | $6.30 | $115.5K | 440,538 | 3 Sep 2026 |
| 2 Sep 2026 | Rodrigues Fernando M., President of BetterHelp | Sale under a trading plan | 5,439 | $6.30 | $34.3K | 9,812 | 3 Sep 2026 |
| 6 Jul 2026 | Bliss Kelly, President, U.S. Group Health | Sale under a trading plan | 2,500 | $9.50 | $23.8K | 84,878 | 6 Jul 2026 |
| 2 Jul 2026 | Catapano Joseph Ronald, Chief Accounting Officer | Sale outside a trading plan | 653 | $9.10 | $5.9K | 12,267 | 6 Jul 2026 |
| 1 Jul 2026 | Bliss Kelly, President, U.S. Group Health | Sale under a trading plan | 2,500 | $9.00 | $22.5K | 87,378 | 1 Jul 2026 |
Planned insider sales
Form 144 notices, filed when the sell order goes to the broker.
| Filed | Seller | Shares | Value | Planned sale |
|---|---|---|---|---|
| 11 Sep 2026 | DIVITA CHARLES III, Officer, Director | 17,805 | $108.7K | 11 Sep 2026 |
| 3 Sep 2026 | Rodrigues Fernando M., Officer | 9,812 | $63.9K | 3 Sep 2026 |
| 2 Sep 2026 | Rodrigues Fernando M., Officer | 5,439 | $34.3K | 2 Sep 2026 |
| 2 Sep 2026 | Nueno Carlos, Officer | 6,200 | $39.1K | 2 Sep 2026 |
| 2 Sep 2026 | Bliss Kelly, Officer | 7,357 | $46.4K | 2 Sep 2026 |
| 2 Sep 2026 | Vandervoort Adam C, Officer | 7,573 | $47.7K | 2 Sep 2026 |
| 2 Sep 2026 | DIVITA CHARLES III, Officer, Director | 18,327 | $115.5K | 2 Sep 2026 |
| 6 Jul 2026 | Bliss Kelly, Officer | 2,500 | $23.8K | 6 Jul 2026 |
| 1 Jul 2026 | Bliss Kelly, Officer | 2,500 | $22.5K | 1 Jul 2026 |
| 29 Jun 2026 | Bliss Kelly, Officer | 2,500 | $21.3K | 29 Jun 2026 |
Large holders
Schedule 13D and 13G filings by holders of more than 5% of the voting shares.
| Filed | Holder | Schedule | Stake | Shares |
|---|---|---|---|---|
| 8 Oct 2026 | Dimensional Fund Advisors LP | 13G | 5% | 9.1M |
| 22 Jun 2026 | Voss Value Master Fund, LP | 13G | 5% | 9.0M |
| 30 Apr 2026 | Vanguard Capital Management | 13G | 5.16% | 9.2M |
| 29 Apr 2026 | Vanguard Portfolio Management | 13G | 6.97% | 12.5M |
| 27 Mar 2026 | The Vanguard Group | 13G amended | 0% | 0 |
| 14 Nov 2025 | Point72 Asset Management, L.P. | 13G amended | 3.3% | 5.8M |
Trades by members of the House
From each member's periodic transaction report.
| Traded | Member | Type | Amount | Disclosed |
|---|---|---|---|---|
| 26 Nov 2021 | Donald Sternoff Honorable Beyer (VA08) | Sale | $1,001 - $15,000 | 2 Dec 2021 |
| 18 Aug 2021 | Donald Sternoff Honorable Beyer (VA08) | Sale | $1,001 - $15,000 | 2 Sep 2021 |
| 21 Jun 2021 | Donald Sternoff Honorable Beyer (VA08) | Sale | $1,001 - $15,000 | 4 Jul 2021 |
| 7 May 2021 | Donald Sternoff Honorable Beyer (VA08) | Sale | $1,001 - $15,000 | 7 Jun 2021 |
| 17 Nov 2020 | Donald Sternoff Beyer (VA08) | Purchase | $1,001 - $15,000 | 1 Dec 2020 |
| 14 Jul 2020 | Donald Sternoff Beyer (VA08) | Sale | $15,001 - $50,000 | 9 Aug 2020 |
| 19 Jun 2019 | Bradley S. Schneider (IL10) | Sale | $250,001 - $500,000 | 21 Jun 2019 |
| 7 May 2019 | Bradley S. Schneider (IL10) | Purchase | $50,001 - $100,000 | 21 Jun 2019 |
Short interest
Shares sold short and not yet bought back, on each FINRA settlement date.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 15 Oct 2026 | 32.1M | +6.54% | 8.21 |
| 30 Sep 2026 | 30.1M | +8.96% | 8.93 |
| 15 Sep 2026 | 27.6M | +9.02% | 8.49 |
| 31 Aug 2026 | 25.3M | +6.98% | 7.17 |
| 14 Aug 2026 | 23.7M | -9.94% | 5 |
| 31 Jul 2026 | 26.3M | -6.26% | 3.96 |
| 15 Jul 2026 | 28.1M | +2.33% | 6.59 |
| 30 Jun 2026 | 27.4M | -6.86% | 5.72 |
Funds that hold it
From each fund's latest Form 13F.
387 funds held it at 30 Jun 2026: 151 added and 89 trimmed in the quarter. The largest:
| Fund | Shares | Value | Change in the quarter |
|---|---|---|---|
| BlackRock, Inc. | 16,223,134 | $137.6M | +1,609,578 |
| Vanguard Portfolio Management LLC | 12,685,592 | $107.6M | +390,498 |
| Point72 Asset Management, L.P. | 8,239,927 | $69.9M | +518,432 |
| Renaissance Technologies LLC | 8,072,842 | $68.5M | -12,700 |
| Voss Capital, LP | 8,046,679 | $68.2M | +3,846,679 |
| Vanguard Capital Management LLC | 7,955,032 | $67.5M | +97,863 |
| Dimensional Fund Advisors LP | 7,371,699 | $62.5M | +1,073,294 |
| State Street Corp. | 4,962,382 | $42.1M | +602,631 |
| American Century Companies Inc. | 4,894,504 | $41.5M | +1,438,120 |
| Allianz Asset Management GmbH | 4,666,596 | $39.6M | -124,767 |
Peers
Companies in the same industry.
- Hims & Hers Health, Inc. (HIMS): revenue $2.6B, market value $6.9B
- Starling Oncology, Inc. (STLN): revenue $587.2M, market value $666.6M
- SBC Medical Group Holdings Inc. (SBC): revenue $175.2M, market value $582.6M